Topic

Cigna

A collection of 1335 issues

Getting Poteligeo (Mogamulizumab-kpkc) Approved by Cigna in Ohio: Coverage Criteria, Appeals, and Documentation Guide

Answer Box: Getting Started Today Cigna requires prior authorization for Poteligeo (mogamulizumab-kpkc) with documented step therapy failure and TNMB staging. Your fastest path: 1) Gather records showing failed systemic therapy (not just topical treatments), 2) Complete Cigna's Poteligeo prior authorization form with full TNMB classification, 3) Submit via
6 min read